Mojtaba Akhtari, M.D.
Academic office: 
UNMC Hematology and Oncology Division
987680 Nebraska Medical Center
Omaha, NE 681980-7680
Ph: 402-559-3834
Fax: 402-559-6520
Main practice location:
Peggy D. Cowdery Patient Care Center
Lied Transplant Center
987835 Nebraska Medical Center
Omaha, NE 68198-7835
Ph: 402-559-8121
Fax: 402-559-6520
Education:
Fellowship in Hematology and Medical Oncology: Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
Residency in Internal Medicine: Saint Francis Hospital of Evanston (Major affiliation with University of Illinois in Chicago), Evanston, Illinois, USA.
Clinical and Laboratory Hematology: Department of Haematological Medicine, King’s College Hospital, London, and Farnborough Hospital, Kent, UK.
Internal Medicine: Bromley Hospitals, Bromley, Kent, and Westmoreland General Hospital, Cumbria, UK.
Tehran University of Medical Sciences, Tehran, Iran, M.D.
Hospital Appointments:
Assistant Professor of Medicine
The University of Nebraska Medical Center
Interests:
Acute and chronic leukemias as well as myelodysplastic syndromes, myeloproliferative disorders, familial leukemias, immune cytopenia, and bone marrow transplantation.
Biographical Sketch:
Dr. Mojtaba Akhtari is a Hematologist/Oncologist with medical and hematology/oncology training and experience in United Kingdom and United States of America. Dr. Akhtari is board certified in Internal Medicine, Hematology and Medical Oncology. His experience is fairly wide ranging having worked in academic teaching medical centers and community hospitals with high clinical workloads and a heavy reliance on clinical skills. He is also a member of adult bone marrow transplantation team. He has authored several book chapters and many articles in peer-reviewed journals. He received Humanism in Medicine Award at St. Francis Hospital of Evanston. He is an active member of the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), and American Society for Blood and Marrow Transplantation (ASBMT). Dr. Akhtari is a member of the Chronic Myeloid Leukemia Panel of the National Comprehensive Cancer Network (NCCN).
Selected Publications:
Prodduturi P, Patricia Aoun P, Weisenburger DD, Perry AM, Akhtari M. Recurrent bone marrow aplasia secondary to nilotinib in a patient with chronic myeloid leukemia: a case report. J Oncol Pharm Pract. 2012 Mar 7. [Epub ahead of print]
O'Brien S, Abboud CN, Akhtari M, Altman J, Berman E, Deangelo DJ, Devine S, Fathi AT, Gotlib J, Jagasia M, Moore JO, Pinilla-Ibarz J, Radich JP, Reddy VV, Shah NP, Shami PJ, Smith BD, Snyder DS, Wetzler M, Yunus F. Chronic myelogenous leukemia. J Natl Compr Canc Netw. 2012; 10: 64-110.
Akhtari M. When to treat patients with myelodysplastic syndromes. Oncology (Williston Park). 2011; 25: 480-486.
Newman KA, Akhtari M. Management of autoimmune neutropenia in Felty’s syndrome and systemic lupus erythematosus. Autoimmun Rev. 2011; 10: 432-437.
Akhtari M, Giver CR, Flowers CR, Gleason CL, Hillyer CD, Kaufman J, Khoury HJ, Langston AA, Lechowicz MJ, Lonial S, Renfroe HM, Tighiouart M, Vaughn L, Waller EK. Receiver operating curve analysis of circulating blood dendritic cells and T-cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Transfusion. 2010; 50: 2424-2431.
Li JM, Giver CR, Lu Y, Hossain MS, Akhtari M, Waller EK. Separating graft versus Leukemia from Graft versus Host Diseases in Allogeneic Hematopoietic Stem Cell Transplantation. Immunotherapy. 2009; 1: 599-621.
Akhtari M, Waller EK. Howell-Jolly body-like inclusions in neutrophils. Blood. 2009, 114: 2860.
Akhtari M, Curtis B, Waller EK. Autoimmune neutropenia in adults. Autoimmun Rev. 2009; 9: 62-66.
Akhtari M, Waller EK, Jaye DL, Lawson DH, Papadopoulos N, Ibrahim R, Arellano ML. Neutropenia in a patient treated with Ipilimumab (anti-CTLA4 antibody). J Immunother. 2009; 32: 322-324.
Akhtari M, Waller EK. Howell-Jolly bodies in patients with chronic GVHD. Blood. 2009; 113: 2125.
Akhtari M, Langton AA, Waller EK, Gal AA. Eosinophilic pulmonary syndrome as a manifestation of graft-versus-host-disease following hematopoietic stem cell transplantation in three patients. Bone Marrow Transplant. 2009; 43: 155-158.
Lim ZY, Ingram W, Brand R, Akhtari M, Milojkovic D, Ho AY, Devereux S, Pagliuca A, Mufti GJ. Clonal gammopathies following alemtuzumab-based reduced intensity conditioning hematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival. Bone Marrow Transplant. 2007, 40: 747-752.
Peyvandi F, Tuddenham EGD, Akhtari M, Lak M, Mannucci PM. Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and VIII. Br J Haematol. 1998; 100: 773-776.
Neerman-Arbez M, Antonarakis SE, Blouin JL, Zeinali S, Akhtari M, Afshar Y, Tuddenham EGD. The locus for combined factor V – factor VIII deficiency (F5F8D) maps to 18q21, between D18s849 and D18s1103. Am J Hum Genet. 1997; 61: 143-150.
